Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1991 1
1992 2
1993 4
1994 1
1995 1
1996 6
1997 3
1998 7
1999 3
2000 10
2001 9
2002 7
2003 9
2004 12
2005 3
2006 3
2007 8
2008 4
2009 11
2010 5
2011 8
2012 10
2013 12
2014 9
2015 13
2016 23
2017 22
2018 24
2019 31
2020 34
2021 25
2022 16
2023 16
2024 20
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway.
Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Kato H, Okada H, Otsuka M. Obata T, et al. Among authors: uchida d. Mol Ther Nucleic Acids. 2023 Oct 28;34:102054. doi: 10.1016/j.omtn.2023.102054. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38111913 Free PMC article.
MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer.
Oda T, Tsutsumi K, Obata T, Ueta E, Kikuchi T, Ako S, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Kato H, Okada H, Chijimatsu R, Otsuka M. Oda T, et al. Among authors: uchida d. Mol Ther Oncol. 2024 Feb 8;32(1):200765. doi: 10.1016/j.omton.2024.200765. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596294 Free PMC article.
Vesnarinone: a differentiation-inducing anti-cancer drug.
Kawamata H, Omotehara F, Nakashiro K, Uchida D, Hino S, Fujimori T. Kawamata H, et al. Among authors: uchida d. Anticancer Drugs. 2003 Jul;14(6):391-5. doi: 10.1097/00001813-200307000-00001. Anticancer Drugs. 2003. PMID: 12853878 Review.
Underwater endoscopic papillectomy using double-balloon endoscopy.
Yamazaki T, Uchida D, Yamasaki Y, Tomoda T, Matsumoto K, Kato H, Okada H. Yamazaki T, et al. Among authors: uchida d. Endoscopy. 2020 Feb;52(2):E55-E56. doi: 10.1055/a-0992-9084. Epub 2019 Sep 9. Endoscopy. 2020. PMID: 31499538 No abstract available.
Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults.
Matsumi A, Tomoda T, Terasawa H, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Tsutsumi K, Kato H. Matsumi A, et al. Among authors: uchida d. Digestion. 2023;104(4):313-319. doi: 10.1159/000529522. Epub 2023 Mar 10. Digestion. 2023. PMID: 36907172
The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study.
Oikawa M, Nishiwaki H, Hasegawa T, Sasaki S, Yazawa M, Miyazato H, Saka Y, Shimizu H, Fujita Y, Murakami M, Uchida D, Kawarazaki H, Omiya S, Sasai F, Koiwa F; JOINT-KD Investigators. Oikawa M, et al. Among authors: uchida d. Nephron. 2024;148(7):448-456. doi: 10.1159/000535874. Epub 2024 Feb 9. Nephron. 2024. PMID: 38342092 Free article.
345 results